← FDA Drug Approvals (Drugs@FDA)
AZACITIDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA MEDICARE · Approved 2016-09-29
Drug application
- FDA Application #
ANDA207518- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AZACITIDINE
- Generic name
- AZACITIDINE
- Active ingredients
- AZACITIDINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- SHILPA MEDICARE
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2016-09-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown